Clinical Trial Update: A Phase II Study of Gleevec and Arsenic Trioxide in Patients With CML Who Fail Gleevec [Phase 2]

View source ↗

Summary

Phase II trial evaluating the combination of imatinib (Gleevec) and arsenic trioxide in chronic myeloid leukemia patients who failed prior Gleevec therapy; stud…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chronic Myeloid Leukemia

Drugs mentioned

• Arsenic Trioxide (arsenic trioxide)
• Gleevec (Imatinib)

Snippet

Sponsor: New Mexico Cancer Research Alliance | Conditions: Leukemia, Other, Cancer | Phase 2 | Status: COMPLETED